Characterization of hits centered around CRC analysis of the primary AC1/CaM FP assay, with counter screening efforts to identify hit compounds that selectively inhibited the AC1/CaM interaction over the AC8/CaM interaction(s). Here, ADCY1 is linked to colorectal carcinoma.